CN102091260A - Chinese medicinal composition for treating bronchitis - Google Patents

Chinese medicinal composition for treating bronchitis Download PDF

Info

Publication number
CN102091260A
CN102091260A CN 201110058645 CN201110058645A CN102091260A CN 102091260 A CN102091260 A CN 102091260A CN 201110058645 CN201110058645 CN 201110058645 CN 201110058645 A CN201110058645 A CN 201110058645A CN 102091260 A CN102091260 A CN 102091260A
Authority
CN
China
Prior art keywords
chinese medicinal
medicinal composition
parts
radix
treating bronchitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 201110058645
Other languages
Chinese (zh)
Other versions
CN102091260B (en
Inventor
李昌学
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011100586457A priority Critical patent/CN102091260B/en
Publication of CN102091260A publication Critical patent/CN102091260A/en
Application granted granted Critical
Publication of CN102091260B publication Critical patent/CN102091260B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a Chinese medicinal composition for treating bronchitis, which is characterized in that: the Chinese medicinal composition is a preparation prepared from the following raw materials in part by weight: 1 part of ginseng, 1 to 1.5 parts of coix seed, 1 to 1.5 parts of root of straight ladybell, 3 to 6 parts of fresh manyflower solomonseal rhizome and 2 to 3 parts of Indian buead. Years of clinical trial observation shows that the Chinese medicinal composition has over 91 percent of effective rate and 85 percent of cure rate.

Description

Treat bronchitic Chinese medicine composition
Technical field
The present invention relates to a kind of medicine for the treatment of pneumonopathy, the bronchitic Chinese medicine composition of particularly a kind of treatment.
Background technology
Bronchitis is meant the chronic nonspecific inflammation of trachea, bronchial mucosa and surrounding tissue thereof.Clinically with long-term cough, expectoration or with pant and repeatedly outbreak for feature, its cause of disease is very complicated, many causes of disease are still indeterminate, modern medicine study shows, chemical toxicant in the atmosphere, irritating smog, the pollution of dust, smoking, antibacterial, viral infection, allergic constitution, weather cold, vitamin A, C shortage etc. all can cause bronchitis, the bronchitic medicine of existing treatment, doctor trained in Western medicine is with control infection such as penicillin, streptomycin, cephalosporin, ribostamycin is main, and be aided with eliminating phlegm and relieving cough such as mixture of ammonium chloride, bromhexine, carbetapentanes etc. improve symptom, though said medicine has certain effect to of short duration relief of symptoms, but be difficult to radical cure, make a lot of bronchitis change into chronic bronchitis.Doctor trained in Western medicine then based on traditional supplementing QI and nourishing YIN, nourishing the lung to arrest cough, eliminate the phlegm, antitussive class Chinese patent medicine, but effect is also not really desirable.
Summary of the invention
The objective of the invention is to overcome the deficiencies in the prior art, provide a kind of good to the tracheitis therapeutic effect, the pharmaceutical composition that cure rate is high, purpose of the present invention realizes by following technical proposals, the present invention by following raw materials according by weight formulated preparation: Radix Ginseng: Semen Coicis: Radix Adenophorae (Radix Glehniae): cadmium yellow essence: Poria=1: 1~1.5: 1~1.5: 3~6: 2~3.
The present invention can make tablet, electuary, decoct, pill, capsule, granule, oral liquid or injection with general conventional formulation method.
Each component of the present invention function in the present invention is as follows:
Radix Ginseng: the energy strongly invigorating primordial QI, strengthening vital QI to eliminate pathogenic factors, lung benefiting gas, spleen reinforcing is calmed the nerves, and is used to control lung qi and loses void, and deficiency of spleen-QI strengthens human body constitution, share better effects if with Poria.Semen Coicis: the energy heat clearing away, control lung abscess and cough vomiting pus expectorant, it is anxious to relax the bronchus contraction, and double spleen-invigorating function, Radix Adenophorae (Radix Glehniae): clearing away lung-heat, tonifying the lung the moon, reinforcing stomach reg fluid.Rhizoma Polygonati: the lung moistening YIN nourishing, invigorating the spleen and replenishing QI is used for deficiency of the lung cough caused by dryness, better effects if with Radix Adenophorae (Radix Glehniae).Poria: mind tranquilizing and the heart calming, spleen invigorating antitussive, above-mentioned each medicine function replenish mutually, and synergism is very good to bronchitic therapeutic effect, observe through the several years clinic trial, and effective percentage reaches more than 91%, and cure rate reaches 85%, sees table 1 for details.
Treat bronchitic Chinese medicine composition curative effect statistical table
Figure BSA00000448876100021
Annotate: the chronic bronchitis classification is to prevent and treat chronic bronchitis clinical speciality meeting revised standard according to the whole nation in 1979 to carry out typing.Male 63 people in the chronic bronchitis, women 46 people, medical history 2-5 24 people, 6-9 37 people, 10-19 51 people, 7 people more than 20 years, recovery from illness is meant to follow up a case by regular visits to more than 1 year not have the recidivist, takes a turn for the better to refer to that symptom obviously alleviates.Therapeutic Method: only take tablet of the present invention during the treatment, each 2~4, every day three times, 7-10 days is a course of treatment.
The present invention is to acute bronchitis as known from Table 2, and cure rate reaches 100%.To chronic bronchitis, effective percentage reaches 91.2%, and wherein cure rate reaches 85%.
From above-mentioned situation as can be known, the objective of the invention is to realize.Good effect compared with prior art, and reliable, products material is easy to get, and makes simple.
The specific embodiment
Embodiment 1, gets the raw materials ready by following component and weight ratio:
Radix Ginseng 500g Semen Coicis 750g Radix Adenophorae (Radix Glehniae) 500g
The smart 2050g Poria of cadmium yellow 1500g.
Preparation method requires to carry out according to dosage form, can be made into agent such as tablet, electuary, decoct, pill, capsule, granule, oral liquid or injection.
Present embodiment is made tablet, and concrete operation method is as follows:
Selected above-mentioned each raw material (roguing), except that the cadmium yellow essence, all the other each group sections in advance, it is standby that 100-200 is pulverized in the back, be after the smart pulverizing of cadmium yellow and add in the cadmium yellow refining material after pulpous state is mixed the above-mentioned each component that crushes, the limit edged stirs, and granulates, and dries to water content 3-5% for 40-60 ℃, capable again tabletting, every 0.5 gram can carry out dry heat sterilization in case of necessity, and packing gets final product.If consider that the shelf-life and the oral property that increase tablet are good, reduce the tablet property of medicine and scatter and disappear, can wrap up a glace.Present embodiment is selected the latter for use, and the present invention can make pill by adding excipient as required certainly.
Embodiment 2, get the raw materials ready by following component and weight ratio:
Radix Ginseng 500g Semen Coicis 500g Radix Adenophorae (Radix Glehniae) 750g
The smart 3000g Poria of cadmium yellow 1000g.
Manufacture method: oral decoct, above-mentioned each component section back decoction is added water 28Kg for the first time to decoct 2 hours, filter and collect filtrate for later use, medicinal residues add water 17Kg again and decoct filtration in 1.5 hours, collect filtrate for later use, medicinal residues continue to add water 11.5Kg and decoct filtration in 1 hour, collect filtrate, above-mentioned each filtrate is merged, place decompression evaporator 40-60 ℃ of (55-120mmHg) evaporation and concentration to 5 times that are equivalent to raw material, add the powdered sugar 1.65Kg that refined, packing, when taking with 1 5-6ml, three times on the one.
Certainly also can further the medicinal liquid after concentrating be made electuary according to a conventional method, promptly concentrating under reduced pressure ml contains raw material 1 gram, adds the dry Icing Sugar after refining, granulate, and dry, packing, every bag of 2g.Take after mixing it with hot water when taking, each 1 bag, every day three times.
Embodiment 3, get the raw materials ready by following component and weight ratio:
Radix Ginseng 500g Semen Coicis 625g Radix Adenophorae (Radix Glehniae) 625g
The smart 1500g Poria of cadmium yellow 1250g.
Method for making is made electuary or capsule according to embodiment 2.
Embodiment 4, get the raw materials ready by following component and weight ratio:
Radix Ginseng 500g Semen Coicis 500g Radix Adenophorae (Radix Glehniae) 500g
The smart 2000g Poria of cadmium yellow 1500g.
The method for making decocting boils three times, filters in each 40 minutes, and three times filtrate merges, be concentrated into 1.5 times of former doses, add 95% ethanol of 3 times of concentrated solutions, fully stir the back and left standstill 24 hours at low temperature (4 ℃), filtered and recycled ethanol adds water for injection to whole liquid measure and reaches the raw material dose to there not being the alcohol flavor, 115 ℃ of heat treatments 30 minutes, 4 ℃ of low temperature are placed and were filtered with the G3 molten funnel that hangs down in 24 hours, the filtrate embedding, 100 ℃ of sterilizations of circulation steam 30 minutes, intramuscular injection during use, each 1ml, every day three times.
The formulation method that the present invention makes is not limited to the several method that embodiment exemplifies.

Claims (2)

1. bronchitic Chinese medicine composition of treatment is characterized in that: by following raw materials according by weight formulated preparation: Radix Ginseng: Semen Coicis: Radix Adenophorae (Radix Glehniae): cadmium yellow essence: Poria=1: 1~1.5: 1~1.5: 3~6: 2~3.
2. bronchitic Chinese medicine composition of the described a kind of treatment of claim 1, it is characterized in that: preparation is tablet, electuary, decoct, pill, capsule, granule, oral liquid or injection.
CN2011100586457A 2011-03-10 2011-03-10 Chinese medicinal composition for treating bronchitis Expired - Fee Related CN102091260B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011100586457A CN102091260B (en) 2011-03-10 2011-03-10 Chinese medicinal composition for treating bronchitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011100586457A CN102091260B (en) 2011-03-10 2011-03-10 Chinese medicinal composition for treating bronchitis

Publications (2)

Publication Number Publication Date
CN102091260A true CN102091260A (en) 2011-06-15
CN102091260B CN102091260B (en) 2012-05-23

Family

ID=44124640

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011100586457A Expired - Fee Related CN102091260B (en) 2011-03-10 2011-03-10 Chinese medicinal composition for treating bronchitis

Country Status (1)

Country Link
CN (1) CN102091260B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1899556A (en) * 2006-07-19 2007-01-24 罗世斌 Medicine for treating trachitis and asthma

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1899556A (en) * 2006-07-19 2007-01-24 罗世斌 Medicine for treating trachitis and asthma

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
《基层医学论坛》 20060425 李斌 中医药治疗慢性支气管炎近况 338-340 1-2 第10卷, 第08期 2 *

Also Published As

Publication number Publication date
CN102091260B (en) 2012-05-23

Similar Documents

Publication Publication Date Title
CN102145061B (en) Qidan nasal allergy medicament and preparation method thereof
CN103330826B (en) Traditional Chinese medicine composition for treating deficiency of lung yin
CN104225194A (en) Traditional Chinese medicine for treating insomnia
CN101912567B (en) Chinese medicinal prescription for treating chronic myocarditis
CN102949700A (en) Chinese medicinal preparation for treating cold stuffy nasal obstruction
CN103446445B (en) Traditional Chinese medicine preparation for treating qi-yin deficiency-type chronic bronchitis and preparation method thereof
CN103330928A (en) Traditional Chinese medicine composition used for treating gastric ulcer and preparation method thereof
CN105641419A (en) Traditional Chinese medicine composition for treating Yin deficiency type cough caused by lung cancer
CN102091260B (en) Chinese medicinal composition for treating bronchitis
CN104324280A (en) Traditional Chinese medicine composition for treating nasopharynx cancer and preparation method of traditional Chinese medicine composition
CN103191345B (en) Postoperative drug for chronic peptic ulcer and esophagitis syndrome
TW201406383A (en) Chinese medicine composition for treating muscular dystrophy, joint deformation and uric acid gout, and preparation method thereof
CN102406854A (en) Chinese medicine composition for treating insomnia
CN101912566B (en) Traditional Chinese medicine for treating palpitation
CN105079580A (en) Traditional Chinese medicine composition for treating wind-warm lung-heat disease
CN108143944A (en) A kind of Chinese medicine composition for treating cold
CN105362596A (en) Traditional Chinese medicine for treating pulmonary emphysema and preparation method thereof
CN105477136A (en) Pharmaceutical composition for treating asthma and preparation method and application of pharmaceutical composition for treating asthma
CN103191344B (en) Method for preparing postoperative drug for chronic peptic ulcer and esophagitis syndrome
CN104352773A (en) Traditional Chinese medicine preparation for treating chronic bronchitis and bronchial asthma
CN104107242A (en) Traditional Chinese medicinal composition for treating hyperthyroidism, and preparation method and application thereof
CN103550509B (en) Chinese medicinal composition for treating lung-qi deficiency type night sweat
CN104083601A (en) Traditional Chinese medicinal preparation for treating diabetes mellitus
CN101862395A (en) Tumor curing medicine containing saussurea involucrate and preparation method thereof
CN108653686A (en) A kind of Chinese medicine composition and preparation method thereof for treating oophoroma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120523

Termination date: 20180310

CF01 Termination of patent right due to non-payment of annual fee